Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study-Reference-Cited by-同舟云学术

Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study

Published:2019-09 Issue:9 Volume:103 Page:1953-1963
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Tedesco-Silva Helio,Pascual Julio,Viklicky Ondrej,Basic-Jukic Nikolina,Cassuto Elisabeth,Kim Dean Y.,Cruzado Josep M.,Sommerer Claudia,Adel Bakr Mohamed,Garcia Valter D.,Uyen Huynh-Do,Russ Graeme,Soo Kim Myoung,Kuypers Dirk,Buchler Matthias,Citterio Franco,Hernandez Gutierrez Maria Pilar,Bernhardt Peter,Chadban Steve

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference38 articles.

1. Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation.;Baroja-Mazo;World J Transplant,2016

2. mTOR signaling in growth control and disease.;Laplante;Cell,2012

3. Efficacy and safety of everolimus for maintenance immunosuppression of kidney transplantation: a meta-analysis of randomized controlled trials.;Liu;PLoS One,2017

4. Efficacy and safety of everolimus plus low-dose calcineurin inhibitor vs. mycophenolate mofetil plus standard-dose calcineurin inhibitor in renal transplant recipients: a systematic review and meta-analysis.;He;Clin Nephrol,2018

5. Everolimus-based calcineurin-inhibitor sparing regimens for kidney transplant recipients: a systematic review and meta-analysis.;Su;Int Urol Nephrol,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous combined transplantation: Intricacies in immunosuppression management;Transplantation Reviews;2024-12

2. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

3. The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients;Kidney International Reports;2024-06

4. The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation;Transplantation;2024-04-12

5. In Vitro Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV;Transplant International;2024-04-09